In the latest episode of the podcast Dominic Tyer speaks with Pierre Bourdage, who’s global head of biopharmaceuticals at Sandoz about the big issues in biosimilars.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
